Transmission of HIV-1 from an obstetrician to a patient during a caesarean section. Authors' replyMALLOLAS, Josep; GATELL, Josep M; BRUGUERA, Miguel et al.AIDS (London). 2006, Vol 20, Num 13, pp 1785-1786, issn 0269-9370, 2 p.Article

MRI signal changes of the bone marrow in HIV-infected patients with lipodystrophy: correlation with clinical parametersGARCIA, Ana I; MILINKOVIC, Ana; TOMAS, Xavier et al.Skeletal radiology. 2011, Vol 40, Num 10, pp 1295-1301, issn 0364-2348, 7 p.Article

Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirinLAUFER, Natalia; LAGUNO, Montserrat; PEREZ, Inaki et al.Antiviral therapy (London). 2008, Vol 13, Num 7, pp 953-957, issn 1359-6535, 5 p.Article

Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patientsCASTRO, Pedro; LAGUNO, Montserrat; NOMDEDEU, Meritxell et al.AIDS research and human retroviruses. 2007, Vol 23, Num 7, pp 863-867, issn 0889-2229, 5 p.Article

Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patientsLAGUNO, Montse; MILINKOVIC, Ana; LARROUSSE, Maria et al.Antiviral therapy (London). 2005, Vol 10, Num 3, pp 423-429, issn 1359-6535, 7 p.Article

Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD study)RIBERA, Esteban; AZUAJE, Carlos; OCANA, Imma et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 40, Num 3, pp 317-323, issn 1525-4135, 7 p.Article

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsLAGUNO, Montserrat; MURILLAS, Javier; LEON, Agathe et al.AIDS (London). 2004, Vol 18, Num 13, pp F27-F36, issn 0269-9370Article

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virusBERENGUER, Juan; VON WICHMANN, Miguel A; TELLEZ, María J et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 12, pp 2843-2849, issn 0305-7453, 7 p.Article

Prevalence and Clinical Relevance of Occult Hepatitis B in the Fibrosis Progression and Antiviral Response to INF Therapy in HIV-HCV-Coinfected PatientsLAGUNO, Montserrat; LARROUSSE, Maria; GATELL, José Maria et al.AIDS research and human retroviruses. 2008, Vol 24, Num 4, pp 547-553, issn 0889-2229, 7 p.Article

Depletion of mitochondrial DNA in liver under anti retroviral therapy with didanosine, stavudine, or zalcitabineWALKER, Ulrich A; BÄUERLE, Jochen; LAGUNO, Montse et al.Hepatology (Baltimore, Md.). 2004, Vol 39, Num 2, pp 311-317, issn 0270-9139, 7 p.Article

Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adultsMARTINEZ, Esteban; MILINKOVIC, Ana; DE LAZZARI, Elisa et al.Lancet (British edition). 2004, Vol 364, Num 9428, pp 65-67, issn 0140-6736, 3 p.Article

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyMARTINEZ, Esteban; BLANCO, José L; CARNE, Xavier et al.AIDS (London). 2001, Vol 15, Num 10, pp 1261-1268, issn 0269-9370Article

Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatographySARASA-NACENTA, Maria; LOPEZ-PUA, Yolanda; MALLOLAS, Josep et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 757, Num 2, pp 325-332, issn 1387-2273Article

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialSULKOWSKI, Mark; POL, Stanislas; WENNING, Larissa et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 597-605, issn 1473-3099, 9 p.Article

A Simplification Trial Swritching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological SuppressionMARTINEZ, Esteban; ARRANZ, José A; BLANCO, José L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 3, pp 290-297, issn 1525-4135, 8 p.Article

Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirinLAGUNO, Montserrat; LARROUSSE, Maria; GATELL, Josep M et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 2, pp 174-178, issn 1525-4135, 5 p.Article

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patientsMILINKOVIC, Ana; MARTINEZ, Esteban; LEON, Agathe et al.Antiviral therapy (London). 2007, Vol 12, Num 3, pp 407-415, issn 1359-6535, 9 p.Article

Transmission of HIV-1 from an obstetrician to a patient during a caesarean sectionMALLOLAS, Josep; ARNEDO, Mireia; PUMAROLA, Tomas et al.AIDS (London). 2006, Vol 20, Num 2, pp 285-287, issn 0269-9370, 3 p.Article

Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapineLEON, Agathe; MARTINEZ, Esteban; MALLOLAS, Josep et al.AIDS (London). 2005, Vol 19, Num 2, pp 213-215, issn 0269-9370, 3 p.Article

Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenzBLANCH, Jordi; MARTINEZ, Esteban; ROUSAUD, Araceli et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 27, Num 4, pp 336-343, issn 1525-4135Article

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosisPINEDA, Juan A; NEUKAM, Karin; DE LOS SANTOS, Ignacio et al.The Journal of infection. 2012, Vol 64, Num 2, pp 204-211, issn 0163-4453, 8 p.Article

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C VirusBERENGUER, Juan; RODRIGUEZ, Elena; JOU, Antoni et al.Clinical infectious diseases. 2012, Vol 55, Num 5, pp 728-736, issn 1058-4838, 9 p.Article

Restoration of T Cell Responses to Toxoplasma gondii after Successful Combined Antiretroviral Therapy in Patients with AIDS with Previous Toxoplasmic EncephalitisLEJEUNE, Marylène; MIRO, José M; FERRER, Elena et al.Clinical infectious diseases. 2011, Vol 52, Num 5, pp 662-670, issn 1058-4838, 9 p.Article

Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C VirusBERENGUER, Juan; ALVAREZ-PELLICER, Julio; GONZALEZ-GARCIA, Juan et al.Hepatology (Baltimore, Md.). 2009, Vol 50, Num 2, pp 407-413, issn 0270-9139, 7 p.Article

Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adultsMALLOLAS, Josep; PICH, Judith; VIDAL, Francesc et al.AIDS (London). 2008, Vol 22, Num 3, pp 377-384, issn 0269-9370, 8 p.Article